Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sagnik Bhattacharyya (S Bhattacharyya)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 24

Top Venues

Brain sciences

Psychological medicine

Translational psychiatry

Psychopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Cathy Davies, Matthijs G Bossong, Daniel Martins, Robin Wilson, Elizabeth Appiah-Kusi, Grace Blest-Hopley, Fernando Zelaya, Paul Allen, Michael Brammer, Jesus Perez, Philip McGuire, Sagnik Bhattacharyya
Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol. Psychological medicine (2023)
Sara Pisani, Luca Gosse, Rita Wieretilo, Dominic Ffytche, Latha Velayudhan, Sagnik Bhattacharyya
Cognitive and executive impairments in Parkinson's disease psychosis: a Bayesian meta-analysis. Journal of neurology, neurosurgery, and psychiatry (2023)
Brandon Gunasekera, Robin Wilson, Aisling O'Neill, Grace Blest-Hopley, Owen O'Daly, Sagnik Bhattacharyya
Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis. Psychological medicine (2022)
Riccardo Bortoletto, Matteo Balestrieri, Sagnik Bhattacharyya, Marco Colizzi
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence. Brain sciences 12 (1) (2022)
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrieri
The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health 19 (9) (2022)
Grace Blest-Hopley, Marco Colizzi, Diana Prata, Vincent Giampietro, Michael Brammer, Philip McGuire, Sagnik Bhattacharyya
Epigenetic Mediation of AKT1 rs1130233's Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing. Brain sciences 11 (9) (2021)
Sara Pisani, Katie McGoohan, Latha Velayudhan, Sagnik Bhattacharyya
Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies. Drugs & aging 38 (10) (2021)
Latha Velayudhan, Katie McGoohan, Sagnik Bhattacharyya
Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis. PLoS medicine 18 (3) (2021)
Ava Mason, Musa Sami, Caitlin Notley, Sagnik Bhattacharyya
Are researchers getting the terms used to denote different types of recreational cannabis right?-a user perspective. Journal of cannabis research 3 (1) (2021)
Cathy Davies, Elizabeth Appiah-Kusi, Robin Wilson, Grace Blest-Hopley, Matthijs G Bossong, Lucia Valmaggia, Michael Brammer, Jesus Perez, Paul Allen, Robin M Murray, Philip McGuire, Sagnik Bhattacharyya
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report. European archives of psychiatry and clinical neuroscience (2021)
Grace Blest-Hopley, Vincent Giampietro, Sagnik Bhattacharyya
A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations. Brain sciences 10 (2) (2020)
Cathy Davies, Robin Wilson, Elizabeth Appiah-Kusi, Grace Blest-Hopley, Michael Brammer, Jesus Perez, Robin M Murray, Paul Allen, Matthijs G Bossong, Philip McGuire, Sagnik Bhattacharyya
A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis. Translational psychiatry 10 (1) (2020)
Natasha Martland, Rebecca Martland, Alexis E Cullen, Sagnik Bhattacharyya
Are adult stressful life events associated with psychotic relapse? A systematic review of 23 studies. Psychological medicine 50 (14) (2020)
E Appiah-Kusi, N Petros, R Wilson, M Colizzi, M G Bossong, L Valmaggia, V Mondelli, P McGuire, Sagnik Bhattacharyya
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis. Psychopharmacology 237 (4) (2020)
Subhadip Paul, Sagnik Bhattacharyya
Cannabis use-related working memory deficit mediated by lower left hippocampal volume. Addiction biology 26 (4) (2020)
Marco Colizzi, Sagnik Bhattacharyya
Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior. Brain sciences 10 (11) (2020)
Musa Basseer Sami, Amanda Worker, Marco Colizzi, Luciano Annibale, Debasis Das, Marlene Kelbrick, Savitha Eranti, Tracy Collier, Chidimma Onyejiaka, Aisling O'Neill, David J Lythgoe, Philip McGuire, Steven C R Williams, Matthew J Kempton, Sagnik Bhattacharyya, null null
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis. Translational psychiatry 10 (1) (2020)
Marco Colizzi, Nathalie Weltens, Philip McGuire, David Lythgoe, Steven C R Williams, Lukas Van Oudenhove, Sagnik Bhattacharyya
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis. Molecular psychiatry 25 (12) (2019)
Grace Blest-Hopley, Aisling O'Neill, Robin Wilson, Vincent Giampietro, David Lythgoe, Alice Egerton, Sagnik Bhattacharyya
Adolescent-onset heavy cannabis use associated with significantly reduced glial but not neuronal markers and glutamate levels in the hippocampus. Addiction biology 25 (6) (2019)
Grace Blest-Hopley, Aisling O'Neill, Robin Wilson, Vincent Giampietro, Sagnik Bhattacharyya
Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use. Psychopharmacology 238 (5) (2019)
Robin Wilson, Matthijs G Bossong, Elizabeth Appiah-Kusi, Natalia Petros, Michael Brammer, Jesus Perez, Paul Allen, Philip McGuire, Sagnik Bhattacharyya
Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis. Translational psychiatry 9 (1) (2019)
Musa Basseer Sami, Sagnik Bhattacharyya
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders. Journal of psychopharmacology (Oxford, England) 32 (8) (2018)
Marco Colizzi, Philip K McGuire, Vincent Giampietro, Steven C R Williams, Mick Brammer, Sagnik Bhattacharyya
Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing. Experimental and clinical psychopharmacology 26 (6) (2018)
Sagnik Bhattacharyya, Alice Egerton, Euitae Kim, Lula Rosso, Daniela Riano Barros, Alexander Hammers, Michael Brammer, Federico E Turkheimer, Oliver D Howes, Philip McGuire
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors. Scientific reports 7 (1) (2017)

Sagnik Bhattacharyya.css-eqlu8i{font-size:small;padding-left:4px;} (S Bhattacharyya)

Publication Activity (10 Years)

Top Topics

Top Venues

Sagnik Bhattacharyya (S Bhattacharyya)